|
Diabetes
Outreach Program Our philosophical orientation makes us vigilant
about the value of health
care – a relationship of the quality, cost-effectiveness and efficacy
of both therapeutic intervention and prevention.
One area of special interest in this regard is disease state
management programs (DSMs). Disease State Management Programs DSMs
are concentrated efforts to reach out to at-risk populations; they help
organized health care delivery systems and their constituencies focus
attention on clinical processes and outcomes. DSMs are becoming available
for cardiovascular disease, congestive heart failure, diabetes, asthma,
depression, arthritis, epigastric pain and peptic ulcer disease, stroke,
AIDS, hemophilia, cancer, hypertension and otitis media. DF: Disease State Management (DSM) With a micro-focus on a specific disease state and individual patient’s needs, DSM programs identify, support and promulgate the best clinical processes across the entire spectrum of health care. Broad in scope, their macro objective is to improve the value of health care through prevention, treatment and outcomes management, continuously. DSMs help with case finding, case management (outreach), compliance and communication (feedback). Standards are also part of disease state management programs; they define what can and should be done for a particular disease state Criteria for Choosing DSMs 1) Do-able -- there is enough of a consensus for an evidence-based approach 2) Opportunity -- serious money can be saved by managing the patient’s care needs, better 3) Customers’ Needs – outcomes are measured, compared, and reported Caveats and Warnings About
DSMs -
Beware
DSMs (esp. those supported by the Pharmaceutical and Research industry)
as being merely: value-added marketing efforts, ploys to get preferred
status of their me-too formulation, foci on parts of a disease or diseases
out of context, and self-serving research. -
Remember
the balloon -- squeeze in one
place; it inflates elsewhere. Also
called the offset effect or tradeoffs in health care, be vigilant that
cost reduction does not compromise quality or access, that unit cost
reduction does not increase frequency, and that reducing the cost of
a piece does not increase costs, overall. -
Although
unlikely to be overt or even conscious, there is evidence of racism
health care DSMs and other programs; this is evidenced by disparities
in the rates of certain procedures.[1] This is also a call for medical schools to
come to terms with the need to enhance culturally sensitive training. That is, in a survey of 78 U.S. medical schools,
only 13 offered courses designed to improve understanding of diverse
ethnic groups; all but one of those courses were elective.[2] -
Managed
Care organizations cannot, shall not, do not practice medicine; this
is a violation of the rule against the corporate practice of medicine. -
Savings
should inure to the customer. -
Non-prescriptive, dynamic guidelines as living
documents that require buy in and do not address cost issues to the
exclusion of quality or customer (real or perceived) need. Diabetes mellitus (DM) is a special DSM because of three reasons: 1) A recognized standard of care has emerged. 2) The disease state, DM is highly amenable to both treatment and prevention. 3) Data are available from the claims trail to help manage most disease states, however, these data require translation into useful clinical information. Survey data such as from patient satisfaction, clinical outcomes, quality of life and degree of function or productivity surveys can be used to supplement them. Diabetes
Mellitus The purpose of any diabetes management program
is to identify those at risk for the complications of diabetes mellitus
(DM) and reduce morbidity and complications, if not death from its ravages. The techniques used to achieve these objectives
include the identification of patients being treated, those at risk
identified through screening techniques, and by reviewing ‘slippage’
-- patients seen in the emergency room, hospital or having complications
of DM that could have been addressed in the ambulatory setting. It is known from the Diabetes Control and Complications
Trial (DCCT)[1]
that intense control (intervention) can reduce or delay diabetic complications
and improve quality of life; correspondingly it can reduce the diabetic’s
use of emergency departments, urgent care facilities and hospitalizations. The Diabetes Outreach Program is predicated
on the findings of the DCCT, extending the capability and capacity of
the practitioner in disease state management (DSM). _____ wants its affected members to receive the education and support
necessary to comprehend the basic pathology of DM; it’s natural history,
consequences, preventive measures and the coping skills necessary to
work with the disease. This
Program is intended to introduce risk-modifying behaviors for all afflicted
or at-risk patients including diet, exercise, and cholesterol control,
the proper use of oral and injectable medications. It reviews and encourages
the self and medical monitoring of blood glucose levels in insulin-dependent
and other diabetics in order to achieve homeostasis.
Finally, the program is designed to improve the patient’s self-management
skills and ability to navigate in a health care delivery system. Intense control of diabetes warrants a multidisciplinary,
team approach that may include the following health care practitioners:
primary care physicians, certified diabetes educators (CDEs are usually
RNs or registered dieticians), ophthalmologists or optometrists, diabetologists
or endocrinologists, podiatrists, utilization or case management nursing
staff, and social workers. The
Diabetes Outreach Program -- Description Patients can self-refer or be referred by their
PCP, a specialist or community outreach programs. 1.
The Diabetes Outreach Program includes a comprehensive,
two-hour review of the pathophysiology of diabetes mellitus; it reinforces
education about primary treatments and prevention including: weight
management, exercise, basic nutrition/meal planning, complications management,
sick day management, medical interventions in identifying low and high
blood sugar states, etc. 2.
Member education will be focused on self-directed
care, empowering the member to be successful with his or her PCP.
These programs will be a joint effort of community resources
and _____ PCPs and specialists physicians, particularly endocrinologists/diabetologists
as mention earlier. 3.
Diabetes Educators – Referral to a participating
Heritage CDE. This referral
will be generated upon Program registration and is valid for 45 days
from the date of each authorization.
PCPs are notified about members who do not schedule appointments
within 45 days of receipt of referral. 4.
Foot Care – _____ recognizes the American Diabetes
Association’s (ADA’s) recommendation about routine and preventive foot
examinations. Therefore, those
members who are considered at risk, especially those with known peripheral
vascular disease (PVD) and/or neuropathy, structural abnormalities,
abnormal gait or a history of foot and lower extremity problems should
be referred to a qualified, network podiatrist.
Patients who smoke, have poor glucose control or who have experienced
foot injury are especially at risk. 5.
Eye Care – Referral to Optometrists/Ophthalmologists
is medically important and should be consummated on a yearly basis.
PCPs should be aware of this standard and help Heritage learn
when this occurs as not every referral to specialists in this field
generates a claim (i.e., sometimes patients choose to see a non-network
provider for some of their care.) Should this care not be documented, Heritage
will survey a sample of its at-risk members and give feedback about
compliance with this standard to the physician-of-record. 6.
Testing – Hemoglobin A-1-Cs are essential at baseline
and quarterly thereafter. 7.
On-Going Support – _____ members are encouraged
to participate in programs conducted by local community resource groups
such as the ADA. 8.
Follow-up on all Diabetes Outreach Program Participants
– All participants will receive follow-up phone calls at one month and
at three-month intervals to gauge their reaction to this program and
their rates of compliance. Outcome
Measurement Outcomes can be measured subjectively by the SF-36
with modification or enhancement for diabetes mellitus. The member following their first diabetes education
class and quarterly (to coincide with the HGB A-1-C measurement) can
complete this questionnaire, thereafter. Objective measurements include: Hgb A-1-C levels,
initially and quarterly; dilated retinal examinations, yearly; body
mass index (BMI = height in cm2/weight in Kg.); blood pressure;
microalbuminuria; Cr.; peripheral pulse palpation; and complications
of DM checked periodically but at least semi-annually. Improving
Compliance with DSMs Improving compliance with difficult treatment regimes
can be difficult. One technique
that has had some success in this regard is establishing, as part of
a diabetic DSM, a "contract" with the afflicted or at-risk
patient. The technique is not a legal arrangement or
obligation. Rather, it is designed
to improve adherence to a diabetes management regime through improved
understanding. The "contract" establishes a moral,
not a financial obligation; it serves to help motivate the patient to
enter into a special, more intense, clearly defined arrangement. It's a compliance issue in the final analysis that establishes goals and parameters for both the health care organization in terms of service that should be provided and the informed patient in terms of their self-care responsibilities. per·sua·sion (per-swa"zhun) n. 1. The
act of persuading or the state of being persuaded.
2. The ability or power to persuade. 3. A strongly held opinion; a conviction.
4.a. A body of religious beliefs; a religion. b. A party, faction, or
group holding to a particular set of ideas or beliefs. 5. Informal.
Kind; sort. un·der·stand·ing (un"der-st˛n"d1ng)
n. 1. The quality or condition of one who understands;
comprehension. 2. The faculty by which one understands; intelligence.
3. Individual or specified judgment or outlook; opinion. 4.a. A compact
implicit between two or more people or groups. b. The matter implicit
in such a compact. 5. A reconciliation
of differences; a state of agreement. Outline of the Diabetes Mellitus DSM Hypothesis: tighter control; healthier patient 1.
Those who might
benefit 1.
Claims and/or
pharmacy data bases are used to identify the at-risk population (1)
L (1)
Insulin (1)
Humulin (DNA)--shorter
onset and briefer duration (2)
Purified pork
(preferred in children--slower onset/more even duration (3)
Iletin (beef/pork),
being phased out (2)
Oral sulfonureas
(Heritage interested in pushing such patients to insulin (in keeping
with the DCCT, notwithstanding items c-e, below (3)
Glipside (Glucotrol;
Phizer) (4)
Glyburide (Micronase;
Upjohn), Diabeta; Hoechst) (5)
Alpha-glucosidase
(Upjohn) (2)
Know full well
that about one-half the type II=s are not even diagnosed (3)
Define the population
who may possibly benefit from the DSM (1)
E.g., gestational
diabetes, not the comfortable 80 year old 2.
Opportunity of
_____ as an integrated health care system 1.
Better communication, better care 2.
Better access
and the concept of the Ateachable moment (1)
Active patient
participation 3.
Better coordination,
a multidisciplinary approach 4.
Processes of
care (1)
E.g., Maternal
care elements (1)
glycosolated
hemoglobins, thyroid, renal scan and lipid laboratory assessments (2)
Opthalmologic
and ECG on selected patients (2)
E.g., Fetal diagnostic
and care elements (1)
ultrasound (level
three) (2)
serum a-fetoprotein,
biophysical measurements (e.g., fetal movement records, fetal heart
rate testing), lung maturation indices 5.
Outcomes of care (1)
hyperbilirubinemia,
hypoglycemia, Type I diabetes, respiratory distress, polycythemia, hypocalcemia (2)
birth defect
rates (3)
congenital anomalies (4)
fetal death rates (5)
preeclampsia,
preterm labor, chronic hypertension, pylonephritis, ketoacidosis, polyhydramnios (6)
macrosomia, C-section 6.
Monitor outcomes,
e.g., maternal and neonatal morbidity, cost-effectiveness, etc. 3.
Infrastructure
Issue: Build a database (DPS) to permit case finding and tracking; 1.
Identification
of patients through pharmaceutical and clinical data bases (DBs) 2.
Prospectively
pick-up patients (1)
Premorbid Conditions
or states (1)
Hgb A1c rising
trend or high absolute values (1)
lower HgbA1c
associated with reduction in fetal malformation rate and prematurity (2)
Microalbinuria (3)
Early onset (4)
Emotional liability (5)
Mild hypertension (2)
Before conception? (1)
Population-based 3.
Materials supplied
by vendor who can be trusted to not be self-serving (1)
Patient Education
materials (1)
Nutritional counseling,
diets, monitoring (2)
Provider Educational
materials, especially (1)
those that test
changes in provider behavior (acceptance of a standard) (3)
Compliance programs (4)
Case Management,
Outreach (5)
Outcomes Studies (1)
HgbA1c (1)
More practical
than evaluating diary of blood glucose levels (Q.I.D, plus) (2)
Nutritional counseling (3)
Increased frequency
of insulin dosing (4)
Handling complications (1)
Retinopathy (2)
Nephropathy;
use of ACE inhibitors (3)
CAD; influence
of medical v. surgical management (4)
Hypertension;
impact of Rx, exercise (5)
Concomitant steroid
uses a confound (6)
Vendors (1)
Diabetes Treatment
Centers of America (relatively neutral) (1)
Network model (2)
Center of excellence
model (preliminary discussion with Westchester) (2)
Phizer (very
impressive patient ed. materials--Diabetes Control Network) (3)
Ely Lilly (4)
Bristol-Meyers
Squibb (5)
Various academic
centers 4.
Goal--see hypothesis 5.
Objectives of
case and DSM--intervening and monitoring disease-state 1.
Decrease acuity
of illness (ER) 2.
Decrease in morbidity
associated with chronicity 3.
Risk (cost of
care); risk of under treatment (1)
Prevent high
cost complications; compression of morbidity/mortality 4.
Improve quality
of life 5.
Reduce voluntary
disenrollments 6.
Development of
a Patient/Physician contract 1.
(See Attachment
#1 from the AAACE Guidelines for the Management of Diabetes Mellitus,@
Jacksonville Florida: May 1, 1994. Endocrine
Practice 1(2):149-57, March/April 1995.) 7. Self-Responsibility/Self-Care--the primary component of diabetes care (See Clinical
Practice Guideline on Diabetes from Humana, attached) 1.
Self-monitoring 2.
Education (Knowledge) 3.
Attention to
all aspects of daily living (1)
Diet/Nutrition (2)
Exercise (3)
Skin Care (4)
Early warning
signs 4.
Doctoring (annual
and periodic) (1)
Blood glucose
monitoring (2)
Cardiovascular,
renal and retinal attention (3)
Immunizations 5.
Compliance-Rx (1) Ability to avoid hypoglycemia, yet have tight control Patient/Physician
Contract, Sample I understand that if I agree to participate in the Diabetes
Self-Management System, I will be expected to do the following: 1. Dedicate myself to getting my blood glucose level
as close to normal as possible by following the instructions of the
Diabetes Self-Management System team 2. Regularly visit the clinic for a physician examination,
laboratory tests, and nutrition counseling; follow-up visits will
be scheduled every 3 months or more frequently if deemed necessary
by my physician or other members of my health care team 3. Bring a detailed one-day food record to each follow-up
visit, to provide necessary nutrition information for myself and my
dietician, and to adjust my eating habits to meet the nutrition goals
established by my dietician 4. Use medication(s) as prescribed by my health care
team 5. Monitor my blood glucose levels at home as instructed,
and bring the results to each follow-up visit 6. Follow my prescribed exercise plan 7. Obtain information as a diabetic in case of an
emergency 8. Ask my physician and other members of my health
care team to explain any aspect of my care that I do not entirely
understand I understand that if I do not monitor myself carefully there
is a risk of hypoglycemia. I also understand that if I do not strive to normalize my blood
sugar, I am at increased risk of developing the complications of diabetes
mellitus. My signature indicates that I have read and understand the
above agreement. Patient Date I agree to provide the leadership for the Diabetes Self-Management
System. Team members will
be available to answer your questions and help you self-manage your
diabetes. I will continue
to encourage you to maintain the best possible control of your diabetes. Physician Date
Figure 1. This sample contract was appended to the
original guideline materials released at AACE |